Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Clinical Therapeutics|March 29, 2017
Cost-effectiveness of Maintaining Daily Intake of Oat β-Glucan for Coronary Heart Disease Primary PreventionStephanie R Earnshaw, Cheryl L McDade, YiFang Chu, et al.Journal of the American Society of Nephrology : JASN|June 20, 2008
Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantationStephanie R Earnshaw, Christopher N Graham, William D Irish, et al.Pharmacoeconomics|March 4, 2010
Cost effectiveness of 5-alpha reductase inhibitors for the prevention of prostate cancer in multiple patient populationsStephanie R Earnshaw, Cheryl L McDade, Libby K Black, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|February 18, 2015
Factor VIII alloantibody inhibitors: cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatmentS R Earnshaw, C N Graham, C L McDade, et al.Applied Health Economics and Health Policy|August 31, 2011
Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE clinical trialMichael W Kattan, Stephanie R Earnshaw, Cheryl L McDade, et al.Current Medical Research and Opinion|September 11, 2007
Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonatesS R Earnshaw, C N Graham, B Ettinger, et al.Microbiology Spectrum|May 9, 2022
Real-World Financial and Clinical Impact of Diagnostic-Driven and Empirical-Treatment Strategies in High-Risk Immunocompromised Patients with Suspected Aspergillus Infection in the United KingdomStephanie R Earnshaw, Cheryl McDade, Andrew Bryan, et al.International Journal of Chronic Obstructive Pulmonary Disease|April 11, 2017
Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic modelMichele R Wilson, Jeetvan G Patel, Amber Coleman, et al.Pharmacoeconomics|June 26, 2010
Economic efficiency of genetic screening to inform the use of abacavir sulfate in the treatment of HIVTeresa L Kauf, Raymond A Farkouh, Stephanie R Earnshaw, et al.Journal of the American College of Surgeons|September 11, 2015
Economic Impact of Alvimopan Considering Varying Definitions of Postoperative IleusStephanie R Earnshaw, Teresa L Kauf, Cheryl McDade, et al.Pageof 5